Cargando…
EFCC1 as a putative prognostic biomarker in lung adenocarcinoma
Autores principales: | Yu, Shengnan, Zhang, Gao |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
AME Publishing Company
2020
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC7475509/ https://www.ncbi.nlm.nih.gov/pubmed/32953781 http://dx.doi.org/10.21037/atm-2020-93 |
Ejemplares similares
-
The Eight EFCC Continuous Postgraduate Course in Clinical Chemistry: New Trends in Classification, Diagnosis and Management of Kidney Diseases
por: Topić, Elizabeta
Publicado: (2009) -
KLRK1 as a prognostic biomarker for lung adenocarcinoma cancer
por: Zhang, Yanan, et al.
Publicado: (2022) -
Prognostic value of biomarkers in the tumor microenvironment of pancreatic ductal adenocarcinoma
por: Mishra, Nitish K., et al.
Publicado: (2020) -
SPP1 and AGER as potential prognostic biomarkers for lung adenocarcinoma
por: Zhang, Weiguo, et al.
Publicado: (2018) -
ROR1 is a novel prognostic biomarker in patients with lung adenocarcinoma
por: Zheng, Yu-Zhu, et al.
Publicado: (2016)